|
|
||||||||
The Journal of Medical Microbiology, Vol 25, Issue 3 191-196, Copyright © 1988 by Society for General Microbiology
JOURNAL ARTICLE |
S. P. Borriello, A. R. Welch, F. E. Barclay and H. A. Davies
Division of Communicable Diseases, Clinical Research Centre, Harrow, Middlesex.
For many organisms, mucosal association is an important virulence determinant. Although studied in detail for other intestinal pathogens, this aspect of pathogenicity has not been studied for Clostridium difficile. We compared the ability of an avirulent non-toxigenic strain (M-1), a highly virulent toxigenic strain (B-1), and a poorly virulent toxigenic strain (BAT) of C. difficile to adhere to different regions of the gastrointestinal tract of hamsters pre-treated with clindamycin. Strain B-1 associated with the gut mucosa significantly better than strain M-1 (p less than 0.001) for all sites other than the caecum, and achieved significantly higher levels in the caecal contents (p less than 0.001). The same was true when strain B-1 was compared with strain BAT except that there was no significant difference for the large bowel mucosa. To assess the possible role of toxin in promoting mucosal association, e.g., by compromising host defences or exposing masked adherence sites, strain M-1 was given to animals after intra-caecal administration of crude toxin preparations from strain-B1, which were heat-inactivated in control experiments. The addition of this toxin increased significantly the mucosal association of M-1 for the small bowel only, whereas the inactivated toxin had no significant effect. These results imply that there may be intrinsic differences between strains in their ability to colonise and associate with the gut mucosa, which may partly depend on their ability to produce toxin. These differences do not correlate with cell-surface hydrophobicity or the presence of plasmids, flagella or fimbriae.
This article has been cited by other articles:
![]() |
J. E. Emerson, R. A. Stabler, B. W. Wren, and N. F. Fairweather Microarray analysis of the transcriptional responses of Clostridium difficile to environmental and antibiotic stress J. Med. Microbiol., June 1, 2008; 57(6): 757 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Keel and J. G. Songer The Distribution and Density of Clostridium difficile Toxin Receptors on the Intestinal Mucosa of Neonatal Pigs Vet. Pathol., November 1, 2007; 44(6): 814 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sebaihia, M. W. Peck, N. P. Minton, N. R. Thomson, M. T.G. Holden, W. J. Mitchell, A. T. Carter, S. D. Bentley, D. R. Mason, L. Crossman, et al. Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes Genome Res., July 1, 2007; 17(7): 1082 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Keel and J. G. Songer The Comparative Pathology of Clostridium difficile-associated Disease Vet. Pathol., May 1, 2006; 43(3): 225 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Freeman, F. J. O'Neill, and M. H. Wilcox Effects of cefotaxime and desacetylcefotaxime upon Clostridium difficile proliferation and toxin production in a triple-stage chemostat model of the human gut J. Antimicrob. Chemother., July 1, 2003; 52(1): 96 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Calabi, F. Calabi, A. D. Phillips, and N. F. Fairweather Binding of Clostridium difficile Surface Layer Proteins to Gastrointestinal Tissues Infect. Immun., October 1, 2002; 70(10): 5770 - 5778. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tasteyre, M.-C. Barc, A. Collignon, H. Boureau, and T. Karjalainen Role of FliC and FliD Flagellar Proteins of Clostridium difficile in Adherence and Gut Colonization Infect. Immun., December 1, 2001; 69(12): 7937 - 7940. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. DRUDY, D.P. O'DONOGHUE, A. BAIRD, L. FENELON, and C. O'FARRELLY Flow cytometric analysis of Clostridium difficile adherence to human intestinal epithelial cells J. Med. Microbiol., June 1, 2001; 50(6): 526 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-J. Waligora, C. Hennequin, P. Mullany, P. Bourlioux, A. Collignon, and T. Karjalainen Characterization of a Cell Surface Protein of Clostridium difficile with Adhesive Properties Infect. Immun., April 1, 2001; 69(4): 2144 - 2153. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tasteyre, T. Karjalainen, V. Avesani, M. Delmée, A. Collignon, P. Bourlioux, and M.-C. Barc Molecular Characterization of fliD Gene Encoding Flagellar Cap and Its Expression among Clostridium difficile Isolates from Different Serogroups J. Clin. Microbiol., March 1, 2001; 39(3): 1178 - 1183. [Abstract] [Full Text] |
||||
![]() |
C. Hennequin, F. Porcheray, A.-J. Waligora-Dupriet, A. Collignon, M.-C. Barc, P. Bourlioux, and T. Karjalainen GroEL (Hsp60) of Clostridium difficile is involved in cell adherence Microbiology, January 1, 2001; 147(1): 87 - 96. [Abstract] [Full Text] |
||||
![]() |
A. Tasteyre, M.-C. Barc, T. Karjalainen, P. Dodson, S. Hyde, P. Bourlioux, and P. Borriello A Clostridium difficile gene encoding flagellin Microbiology, April 1, 2000; 146(4): 957 - 966. [Abstract] [Full Text] |
||||
![]() |
A.-J. Waligora, M.-C. Barc, P. Bourlioux, A. Collignon, and T. Karjalainen Clostridium difficile Cell Attachment Is Modified by Environmental Factors Appl. Envir. Microbiol., September 1, 1999; 65(9): 4234 - 4238. [Abstract] [Full Text] |
||||
![]() |
J. A. Kink and J. A. Williams Antibodies to Recombinant Clostridium difficile Toxins A and B Are an Effective Treatment and Prevent Relapse of C. difficile-Associated Disease in a Hamster Model of Infection Infect. Immun., May 1, 1998; 66(5): 2018 - 2025. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |